AST (Aspartate Aminotransferase)

← Back to Lab Reference Library

Category: Liver & Kidney  |  Also known as: SGOT, Aspartate Aminotransferase  |  Sample: Serum (fasting preferred)

1. What This Test Measures

AST (Aspartate Aminotransferase) is an enzyme that catalyzes the transfer of an amino group from aspartate to alpha-ketoglutarate in amino acid metabolism. Unlike ALT, which is concentrated almost exclusively in the liver, AST is found in significant amounts in multiple tissues: liver, skeletal muscle, cardiac muscle, kidney, brain, and red blood cells. This broader tissue distribution makes AST less liver-specific than ALT but essential for completing the liver enzyme pattern and for identifying muscle and cardiac injury.

In clinical practice, AST's most critical role is not its absolute value but its relationship to ALT. The AST/ALT ratio is one of the most diagnostically powerful patterns in liver medicine, distinguishing alcoholic from non-alcoholic liver disease, identifying cirrhosis, and differentiating hepatic from muscular enzyme sources. AST without ALT (and GGT and ALP) provides only partial information.

2. Why This Test Matters

• AST/ALT ratio for alcoholic liver disease: an AST/ALT ratio above 2 (with AST typically below 300 U/L) is strongly associated with alcoholic liver disease. Alcohol preferentially damages mitochondria and depletes pyridoxal phosphate (a cofactor preferentially required for ALT production), causing AST to dominate the enzyme pattern. This ratio is one of the few non-invasive clinical tools that reliably distinguishes alcoholic from non-alcoholic etiology.
• Cirrhosis detection: in established cirrhosis, AST/ALT often exceeds 1 even in non-alcoholic patients because progressive fibrosis and hepatocyte loss disproportionately reduces the liver's ability to produce ALT. Rising AST/ALT ratio over time in a NAFLD patient may signal advancing fibrosis.
• Muscle injury identification: elevated AST with normal or only mildly elevated ALT, and markedly elevated CK (creatine kinase), identifies skeletal or cardiac muscle as the enzyme source rather than the liver. This pattern is critical for avoiding unnecessary hepatic workup in athletes with post-exercise enzyme elevations.
• Cardiac injury historical context: prior to the widespread availability of cardiac troponin, AST was used to diagnose myocardial infarction (along with LDH). It is now replaced by troponin for cardiac evaluation, but AST from cardiac muscle release must still be considered when interpreting an isolated elevated AST with normal ALT.
• Hemolysis detection: AST is released from red blood cells in hemolysis. Elevated AST with normal ALT and elevated LDH alongside reduced haptoglobin and elevated indirect bilirubin suggests hemolysis rather than liver disease.

3. Standard Lab Reference Range

Population	Standard Range	Units
Men (adult)	10 to 40	U/L
Women (adult)	9 to 32	U/L

Reference ranges vary by laboratory. AST rises significantly after strenuous exercise (10-fold elevation possible within hours of intense resistance training), making it critical to avoid drawing liver enzymes within 48 to 72 hours of exercise when evaluating AST for hepatic causes.

4. Optimal Functional Medicine Range

AST Level	Functional Interpretation
Below 20 U/L	Optimal: minimal hepatocellular stress (in non-exercising individual)
20 to 25 U/L	Low-normal: acceptable; confirm with ALT pattern and exercise history
25 to 40 U/L	Borderline: evaluate AST/ALT ratio; rule out exercise, muscle disease, alcohol
40 to 120 U/L	Mild to moderate elevation: evaluate complete liver panel; evaluate for alcohol, NAFLD, medications, muscle injury
120 to 400 U/L	Moderate to significant: acute hepatocellular or muscle injury; urgent evaluation
Above 400 U/L	Markedly elevated: severe injury (ischemia, toxic hepatitis, rhabdomyolysis, acute MI); urgent evaluation

5. The AST/ALT Ratio: The Most Clinically Important Pattern

AST/ALT Ratio	Clinical Interpretation	Next Steps
Below 0.8	ALT dominant: NAFLD or viral hepatitis pattern	Screen for hepatitis B and C; evaluate for metabolic syndrome
0.8 to 1.0	Near equal: non-specific; consider all causes	Evaluate with GGT, ALP, and clinical context
1.0 to 2.0	AST slightly dominant: early fibrosis, cirrhosis, or alcohol in early stage	Evaluate for liver fibrosis; consider FibroScan or fibrosis scoring
Above 2.0	AST strongly dominant: strongly suggests alcoholic liver disease	Detailed alcohol history; GGT usually markedly elevated; abstinence and monitoring
AST elevated, ALT normal	Non-hepatic source: muscle, heart, or hemolysis	Check CK (muscle), troponin (heart), LDH and haptoglobin (hemolysis)

6. What Causes Elevated AST

• NAFLD and metabolic liver disease: most common cause; typically AST below ALT (AST/ALT less than 1)
• Alcoholic liver disease: AST typically exceeds ALT; AST/ALT ratio above 2 is the diagnostic hallmark; AST rarely exceeds 300 U/L even in severe alcoholic hepatitis
• Strenuous exercise and muscle injury: can elevate AST 10-fold within hours; post-exercise AST elevation with normal ALT and markedly elevated CK is diagnostic of muscle source; normalizes within 3 to 5 days of rest
• Viral hepatitis: acute hepatitis A, B, C, D, or E; typically ALT exceeds AST; both enzymes can reach 1,000 to 5,000 U/L in acute hepatitis
• Ischemic hepatitis: from congestive heart failure, shock, or hepatic artery occlusion; both AST and ALT can reach 1,000 to 10,000 U/L rapidly; often first clue to cardiac or hemodynamic compromise
• Myocardial infarction: historically elevated AST from cardiac muscle necrosis; now evaluated with troponin but AST may still be elevated in large MI
• Rhabdomyolysis: severe skeletal muscle breakdown from extreme exertion, statin myopathy, crush injury, or severe hypothyroidism; CK dramatically elevated (often above 10,000 U/L) with elevated AST and normal or mildly elevated ALT
• Cirrhosis: as liver fibrosis advances, AST/ALT ratio rises above 1 even in non-alcoholic patients due to relative loss of hepatocyte ALT-producing capacity
• Hemolysis: RBC release AST; elevated LDH, low haptoglobin, and elevated indirect bilirubin confirm hemolytic source
• Autoimmune hepatitis: typically moderate to significant elevation; confirm with ANA, anti-smooth muscle antibody, and liver biopsy

7. How to Improve This Marker

8. The Complete Liver Enzyme Panel: Pattern Interpretation

No single liver enzyme is interpreted in isolation. The pattern of ALT, AST, GGT, and ALP together determines the clinical direction:

Pattern	ALT	AST	GGT	ALP	Most Likely Cause
NAFLD	High	Mildly high	Mildly high	Normal	Non-alcoholic fatty liver disease; metabolic liver injury
Alcoholic hepatitis	Elevated	Greater than 2x ALT	Markedly high	Normal to mild	Alcohol; AST/ALT ratio above 2 is hallmark
Biliary obstruction	Mildly elevated	Mildly elevated	High	Markedly high	Choledocholithiasis, cholangiocarcinoma, pancreatic mass
Bone source	Normal	Normal or mild	Normal	Elevated	Paget's disease, bone metastases, healing fracture
Viral hepatitis (acute)	Very high	High	Elevated	Mildly elevated	Hepatitis A, B, C, E
Muscle injury	Normal or mild	Elevated	Normal	Normal	Rhabdomyolysis, myopathy, post-exercise; CK markedly elevated

9. Related Lab Tests

10. When Testing Is Recommended

• Always interpret alongside ALT, GGT, and ALP; AST without the complete pattern provides limited clinical information
• Standard annual metabolic panel
• Alcohol use evaluation; AST is the most sensitive standard enzyme for alcohol-related liver injury
• Metabolic syndrome and insulin resistance; NAFLD is the most common cause of elevated AST in this population
• Suspected muscle disease: always measure CK alongside AST if muscle source is suspected
• Statin or other hepatotoxic medication monitoring; baseline and periodic AST and ALT required
• Evaluation of exercise-related enzyme elevation; wait 48 to 72 hours after intense training

11. Clinical Perspective

12. Frequently Asked Questions